Table 6.
Endorsed Side Effects of Cannabigerol-Predominant Cannabis and Percentage of Sessions for Which Side Effects Were Experienced (N=127)
Medical condition | % endorsed | N | Range | Mean, % | Standard error |
---|---|---|---|---|---|
Dry mouth | 16.5 | 21 | 9–100 | 52.71 | 5.66 |
Sleepiness | 15 | 18 | 11–90 | 52.89 | 5.75 |
Increased appetite | 11.8 | 14 | 9–90 | 51.14 | 6.42 |
Dry eyes | 8.7 | 11 | 25–90 | 49.82 | 6.77 |
Nervousness/anxiety | 6.3 | 8 | 5–58 | 26.25 | 6.04 |
Difficulty concentrating | 6.3 | 6 | 30–100 | 59.18 | 10.44 |
Headrush/lightheaded/dizzy | 6.3 | 7 | 2–74 | 28.57 | 11.49 |
Headache/migraine | 5.5 | 7 | 2–60 | 21.57 | 7.91 |
More high | 4.7 | 6 | 10–100 | 60.3 | 12.33 |
Heart palpitations/racing heart | 3.1 | 3 | 30–51 | 40.33 | 6.06 |
Off-balance/unsteady | 2.4 | 2 | 46–50 | 48 | 2 |
Paranoia | 1.6 | 2 | 14–30 | 22 | 8 |
Hot flashes | 0.8 | 1 | 91–91 | 91 | 0 |
Coughing fit | 0 | ||||
Hallucinations | 0 | ||||
Vomiting | 0 | ||||
Other | 9.4 | 11 | 10–100 | 46.55 | 10.57 |